DFFVX
Price
$35.41
Change
-$0.43 (-1.20%)
Updated
Nov 13 closing price
Net Assets
13.3B
GSXPX
Price
$59.44
Change
-$1.14 (-1.88%)
Updated
Nov 13 closing price
Net Assets
849.46M
Interact to see
Advertisement

DFFVX vs GSXPX

Header iconDFFVX vs GSXPX Comparison
Open Charts DFFVX vs GSXPXBanner chart's image
DFA US Targeted Value I
Price$35.41
Change-$0.43 (-1.20%)
VolumeN/A
Net Assets13.3B
Goldman Sachs Small Cp Val Insghts P
Price$59.44
Change-$1.14 (-1.88%)
VolumeN/A
Net Assets849.46M
DFFVX vs GSXPX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. GSXPX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and GSXPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.3B vs. GSXPX (849M). DFFVX pays higher dividends than GSXPX: DFFVX (1.72) vs GSXPX (0.67). DFFVX was incepted earlier than GSXPX: DFFVX (26 years) vs GSXPX (8 years). GSXPX (0.88) is less costly to investors than DFFVX (0.30). GSXPX is a more actively managed with annual turnover of: 152.00 vs. DFFVX (7.00). DFFVX (0) and GSXPX (0) have matching initial minimum investment requirements. DFFVX annual gain was more profitable for investors over the last year : -0.18 vs. GSXPX (-10.90). DFFVX return over 5 years is better than : 79.20 vs. GSXPX (25.43).
DFFVXGSXPXDFFVX / GSXPX
Total Expense Ratio0.290.8335%
Annual Report Gross Expense Ratio0.300.8834%
Fund Existence26 years8 years-
Gain YTD5.7699.70759%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets13.3B849M1,567%
Annual Yield % from dividends1.720.67257%
Returns for 1 year-0.18-10.902%
Returns for 3 years25.6917.91143%
Returns for 5 years79.2025.43311%
Returns for 10 years80.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNAP9.090.33
+3.77%
Snap
NCSM38.280.95
+2.53%
NCS Multistage Holdings
OCUL11.490.27
+2.41%
Ocular Therapeutix
ISPC0.63N/A
-0.45%
iSpecimen Inc
BWMX14.11-0.11
-0.77%
Betterware de Mexico SAPI de CV